Guangzhou Baiyunshan Pharmaceutical Holdings Future Growth
Future criteria checks 1/6
Guangzhou Baiyunshan Pharmaceutical Holdings is forecast to grow earnings and revenue by 3.4% and 6.1% per annum respectively. EPS is expected to decline by 2.7% per annum. Return on equity is forecast to be 10% in 3 years.
Key information
3.4%
Earnings growth rate
-2.7%
EPS growth rate
Healthcare earnings growth | 21.9% |
Revenue growth rate | 6.1% |
Future return on equity | 10.0% |
Analyst coverage | Good |
Last updated | 21 Mar 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 90,933 | 4,415 | N/A | 3,638 | 3 |
12/31/2025 | 85,609 | 4,436 | N/A | 4,546 | 6 |
12/31/2024 | 80,799 | 4,174 | N/A | 6,190 | 5 |
12/31/2023 | 75,515 | 4,056 | 2,475 | 4,104 | N/A |
9/30/2023 | 74,167 | 4,283 | 2,958 | 4,601 | N/A |
6/30/2023 | 73,538 | 4,188 | 2,954 | 4,546 | N/A |
3/31/2023 | 71,878 | 4,069 | 1,898 | 3,242 | N/A |
12/31/2022 | 70,788 | 3,967 | 5,615 | 6,999 | N/A |
9/30/2022 | 70,280 | 3,883 | 1,805 | 3,187 | N/A |
6/30/2022 | 70,106 | 3,807 | 3,878 | 5,201 | N/A |
3/31/2022 | 69,507 | 3,898 | 3,606 | 4,910 | N/A |
12/31/2021 | 69,014 | 3,720 | 4,419 | 5,673 | N/A |
9/30/2021 | 68,329 | 3,568 | 4,862 | 5,982 | N/A |
6/30/2021 | 67,333 | 3,653 | 4,133 | 5,174 | N/A |
3/31/2021 | 64,735 | 3,359 | 4,726 | 5,674 | N/A |
12/31/2020 | 61,674 | 2,915 | -291 | 585 | N/A |
9/30/2020 | 61,774 | 2,688 | 3,526 | 4,389 | N/A |
6/30/2020 | 62,081 | 2,406 | 2,641 | 3,543 | N/A |
3/31/2020 | 63,881 | 2,966 | 2,041 | 4,414 | N/A |
12/31/2019 | 64,952 | 3,189 | 2,623 | 5,022 | N/A |
9/30/2019 | 62,420 | 3,161 | 563 | 2,884 | N/A |
6/30/2019 | 60,735 | 3,370 | 911 | 3,088 | N/A |
3/31/2019 | 53,380 | 3,943 | 1,003 | 1,616 | N/A |
12/31/2018 | 42,234 | 3,441 | 4,738 | 5,217 | N/A |
9/30/2018 | 34,863 | 4,015 | 3,077 | 3,378 | N/A |
6/30/2018 | 24,679 | 3,523 | 1,918 | 2,171 | N/A |
3/31/2018 | 22,575 | 2,482 | 2,065 | 2,280 | N/A |
1/1/2018 | 20,954 | 2,062 | 1,637 | 1,834 | N/A |
9/30/2017 | 20,459 | 1,937 | N/A | 1,888 | N/A |
6/30/2017 | 20,294 | 1,834 | N/A | 1,649 | N/A |
3/31/2017 | 20,273 | 1,583 | N/A | 2,157 | N/A |
12/31/2016 | 20,036 | 1,508 | N/A | 2,545 | N/A |
9/30/2016 | 19,598 | 1,397 | N/A | 2,806 | N/A |
6/30/2016 | 19,502 | 1,357 | N/A | 2,427 | N/A |
3/31/2016 | 19,442 | 1,345 | N/A | 2,442 | N/A |
12/31/2015 | 19,125 | 1,300 | N/A | 1,942 | N/A |
9/30/2015 | 19,244 | 1,300 | N/A | 1,499 | N/A |
6/30/2015 | 19,270 | 1,295 | N/A | 1,859 | N/A |
3/31/2015 | 18,876 | 1,241 | N/A | 1,827 | N/A |
12/31/2014 | 18,818 | 1,194 | N/A | 1,749 | N/A |
9/30/2014 | 19,049 | 1,106 | N/A | 1,902 | N/A |
6/30/2014 | 18,563 | 1,067 | N/A | 1,136 | N/A |
3/31/2014 | 18,130 | 1,036 | N/A | 895 | N/A |
12/31/2013 | 17,608 | 980 | N/A | 1,336 | N/A |
9/30/2013 | 16,744 | 891 | N/A | 1,253 | N/A |
6/30/2013 | 15,485 | 889 | N/A | 1,585 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 600332's forecast earnings growth (3.4% per year) is above the savings rate (2.9%).
Earnings vs Market: 600332's earnings (3.4% per year) are forecast to grow slower than the CN market (23.8% per year).
High Growth Earnings: 600332's earnings are forecast to grow, but not significantly.
Revenue vs Market: 600332's revenue (6.1% per year) is forecast to grow slower than the CN market (14.4% per year).
High Growth Revenue: 600332's revenue (6.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 600332's Return on Equity is forecast to be low in 3 years time (10%).